"All of these agents are clearly active -- I want all three of these on my team when I treat breast cancer," said Vogelzang, who is medical director of the developmental therapeutics committee at the Comprehensive Cancer Care Centers of Nevada.
Findings presented at medical meetings should be viewed as preliminary until published in a peer-reviewed journal.
There's more on the treatment of breast cancer at the American Cancer Society.
Copyright © 2012 HealthDay. All rights reserved.